µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå : À¯Çüº°, °ø±Þ¿øº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Animal Antibacterial Peptide Market, By Type, By Source, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1532822
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 369 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,518,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,464,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,855,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå ±Ô¸ð´Â 2023³â 34¾ï 5,123¸¸ ´Þ·¯·Î 2024-2032³â ¿¬Æò±Õ 16.5% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - ½ÃÀå ¿ªÇÐ

ƯÁ¤ º´¿øÃ¼¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ½Å±Ô ÆéŸÀ̵忡 ´ëÇÑ ¼ö¿ä Áõ°¡·Î µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁø

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀåÀº µ¿¹° ÀÇ·á ºÐ¾ß¿¡¼­ º¸´Ù Á¤¹ÐÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ¸·ÎÀÇ ÀüȯÀ» ¹Ý¿µÇÏ¿© ƯÁ¤ º´¿ø±ÕÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â »õ·Î¿î ÆéŸÀ̵忡 ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ´«¿¡ ¶ç°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ³ó¹«ºÎ(USDA)ÀÇ ¿¬±¸¿¡ µû¸£¸é ´ëÀå±Õ°ú »ì¸ð³Ú¶ó±ÕÀ» Ç¥ÀûÀ¸·Î ÇÏ´Â ÆéŸÀ̵尡 °¡ÃàÀÇ °¨¿°·üÀ» ÃÖ´ë 50%±îÁö °¨¼Ò½ÃŰ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, Journal of Veterinary Science Àú³Î¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, Á¶Á¤µÈ Ç×±Õ ÆéŸÀ̵尡 °¡±Ý·ùÀÇ È£Èí±â °¨¿° ¹ß»ý·üÀ» 30% °¡±îÀÌ °¨¼Ò½Ãų ¼ö ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Elanco¿Í Zoetis¿Í °°Àº À¯¸í Á¦¾àȸ»çµéÀÌ ÆéŸÀÌµå ±â¹Ý Ä¡·áÁ¦ °³¹ß¿¡ ¸¹Àº ÀÚ¿øÀ» ÅõÀÔÇϰí ÀÖÀ¸¸ç, ÀÌ ºÎ¹®ÀÇ R&D ÀÚ±ÝÀº Áö³­ 2³â µ¿¾È ¾à 20% Áõ°¡Çß½À´Ï´Ù.

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 16.5%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çüº°·Î´Â ÇÕ¼º ÆéŸÀ̵尡 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

°ø±Þ¿øº°·Î´Â 2023³â µ¿¹° À¯·¡°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â µ¿¹°¿ë ÀǾàǰÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ²ÅÇû½À´Ï´Ù.

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ¼¼°è ½ÃÀåÀº À¯Çü, °ø±Þ¿ø, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó ÇÕ¼º ÆéŸÀ̵å¿Í õ¿¬ ÆéŸÀ̵åÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÇÕ¼º ÆéŸÀ̵å´Â Ç¥Àû Àû¿ë°ú È®À强À» À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, õ¿¬ ÆéŸÀ̵å´Â µ¿¹°¿¡¼­ À¯·¡ÇÑ °ÍÀ¸·Î °íÀ¯ÇÑ Ç×±Õ Æ¯¼º°ú »ý¹°ÇÐÀû ÀûÇÕ¼ºÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀåÀº °ø±Þ¿ø¿¡ µû¶ó ¹Ì»ý¹° À¯·¡, ½Ä¹° À¯·¡, µ¿¹° À¯·¡ÀÇ ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¼¼±Õ À¯·¡´Â ´Ù¾çÇÑ Ç×±Õ ÆéŸÀ̵带 Á¦°øÇϰí, ½Ä¹° À¯·¡´Â Ç×±Õ Æ¯¼ºÀ» °¡Áø »ý¹° Ȱ¼º È­ÇÕ¹°À» Á¦°øÇϸç, µ¿¹° À¯·¡´Â õ¿¬ À¯·¡ÀÇ °­·ÂÇÑ Ç×±Õ È¿°ú¸¦ °¡Áø ÆéŸÀ̵带 Á¦°øÇÕ´Ï´Ù.

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

¹Ì±¹°ú ij³ª´Ù·Î ´ëÇ¥µÇ´Â ºÏ¹Ì´Â ÷´Ü ¿¬±¸ ½Ã¼³°ú Çõ½ÅÀûÀÎ ¼öÀÇÇÐ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °­ÇÑ °ü½ÉÀ¸·Î ÀÎÇØ ÁÖ¿ä Çãºê ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¹Ì±¹ ³ó¹«ºÎ¿Í ¸¹Àº Çмú ±â°üÀÌ ÆéŸÀÌµå ¿¬±¸¿¡ Àû±ØÀûÀ¸·Î ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯·´, ƯÈ÷ ¼­À¯·´Àº ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁذú °¡Ãà °ü¸®¿¡¼­ ´ëü Ä¡·á¹ýÀÇ Ã¤Åà Áõ°¡·Î ÀÎÇØ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡µéÀÌ ´ë±Ô¸ð ³ó¾÷ ºÎ¹®°ú °¡ÃàÀÇ °Ç°­ ÁõÁø¿¡ ÁßÁ¡À» µÎ¸é¼­ ÁÖ¿ä ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù º¸°í¼­¿¡ µû¸£¸é Áß±¹¿¡¼­´Â ÆéŸÀÌµå ±â¹Ý µ¿¹°¿ë ÀǾàǰ¿¡ ´ëÇÑ ÅõÀÚ°¡ Áö³­ 1³â µ¿¾È ¾à 25% ±ÞÁõÇßÀ¸¸ç, Àεµ¿¡¼­´Â È®´ëµÇ´Â Ãà»ê ºÎ¹®ÀÌ Áõ°¡ÇÏ´Â Áúº´ ¹ß»ý¿¡ ´ëóÇϱâ À§ÇØ ÀÌ·¯ÇÑ ½Å±â¼úÀ» ºü¸£°Ô äÅÃÇϰí ÀÖ½À´Ï´Ù.

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - °æÀï »óȲ:

µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀåÀÇ °æÀï ±¸µµ´Â ´ëÇü Á¦¾à»ç¿Í ÷´Ü »ý¸í°øÇÐ ±â¾÷ÀÇ È°¹ßÇÑ À¶ÇÕÀ¸·Î Á¤ÀÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡¼­´Â Zoetis, Elanco, Merck¿Í °°Àº ¼±µµ ±â¾÷µéÀÌ ±¤¹üÀ§ÇÑ R&D ¿ª·®°ú È®°íÇÑ ½ÃÀå ÀÔÁö¸¦ Ȱ¿ëÇÏ¿© ÆéŸÀÌµå ±â¹Ý Ä¡·á¹ýÀÇ ¹ßÀüÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷À» º¸¿ÏÇÏ´Â °ÍÀº ÷´Ü ±â¼ú°ú Âü½ÅÇÑ ÆéŸÀÌµå ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ½Å»ý »ý¸í°øÇÐ ±â¾÷µéÀÔ´Ï´Ù. ÃÖ±Ù ¿¤¶ûÄÚ¿Í ÆéƼ½Ã½ºÅÛÁî(PeptiSystems)°¡ °¡Ãà¿ë Ç¥Àû Ç×±Õ ÆéŸÀ̵带 °øµ¿ °³¹ßÇϱâ À§ÇØ ¸ÎÀº Àü·«Àû Á¦ÈÞ´Â ÀÌ ½ÃÀå¿¡¼­ ´«¿¡ ¶ç´Â »ç·ÊÀÔ´Ï´Ù. ÀÌ Á¦ÈÞ´Â Ç×»ýÁ¦ ³»¼º °¨¿°ÀÇ Áõ°¡¶ó´Â µµÀü¿¡ ´ëÀÀÇϱâ À§ÇØ Àü¹®¼ºÀ» °áÁýÇÏ·Á´Â ¾÷°èÀÇ ¿òÁ÷ÀÓÀ» Àß º¸¿©ÁÝ´Ï´Ù.

¸ñÂ÷

Á¦1Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀ̵åÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå »ê¾÷ ¿¬±¸

Á¦5Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå »óȲ

Á¦7Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - À¯Çüº°

Á¦8Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - °ø±Þ¿øº°

Á¦9Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - ¿ëµµº°

Á¦10Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - µ¿¹°¿ë Ç×±Õ ÆéŸÀÌµå ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Animal Antibacterial Peptide Market size was valued at USD 3,451.23 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The Animal Antibacterial Peptide (AAP) Market comprises peptides derived from animals that exhibit antimicrobial properties, crucial for developing new therapeutics and improving disease management in livestock and companion animals. The rising incidence of antibiotic-resistant infections in animals and the growing demand for alternative treatments are key factors propelling market growth. Conversely, high production costs and regulatory challenges associated with peptide-based products pose significant restraints. Opportunities abound in expanding applications in veterinary medicine and the development of novel peptides targeting specific pathogens. For instance, recent studies have highlighted that antimicrobial peptides can reduce infection rates in livestock by up to 40%, while investment in peptide research has increased by approximately 15% over the past year.

Animal Antibacterial Peptide Market- Market Dynamics

Rising Demand for Novel Peptides Targeting Specific Pathogens Fuels Growth in the Animal Antibacterial Peptide Market

The Animal Antibacterial Peptide Market is experiencing notable growth driven by the increasing demand for novel peptides that target specific pathogens, reflecting a shift towards more precise and effective treatments in veterinary medicine. For instance, research from the USDA has highlighted that peptides specifically targeting E. coli and Salmonella have shown up to a 50% reduction in infection rates among livestock. Furthermore, a study published in the Journal of Veterinary Science reported that tailored antimicrobial peptides could decrease the incidence of respiratory infections in poultry by nearly 30%. This trend is supported by investment from prominent pharmaceutical companies, such as Elanco and Zoetis, which are allocating significant resources to develop peptide-based therapies, with R&D funding in this area increasing by around 20% over the past two years.

Animal Antibacterial Peptide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, Synthetic Peptides were predicted to show maximum market share in the year 2023

Based on Source segmentation, Animal Sources was the leading type in 2023

Based on Application segmentation, Veterinary Medicine was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Animal Antibacterial Peptide Market- Segmentation Analysis:

The Global Animal Antibacterial Peptide Market is segmented based on Type, Source, Application, End-User, and Region.

The market is divided into two categories based on Type: Synthetic Peptides and Natural Peptides. Synthetic Peptides are engineered for targeted applications and scalability, while Natural Peptides, derived from animal sources, offer inherent antimicrobial properties and biological compatibility.

The market is divided into three categories based on Sources: Bacterial Sources, Plant Sources, and Animal Sources. Bacterial Sources provide diverse antimicrobial peptides, Plant Sources offer bioactive compounds with antimicrobial properties, and Animal Sources yield peptides with potent, naturally occurring antimicrobial effects.

Animal Antibacterial Peptide Market- Geographical Insights

North America, led by the United States and Canada, remains a major hub due to advanced research facilities and a strong focus on innovative veterinary solutions, with the USDA and numerous academic institutions actively contributing to peptide research. Europe, particularly Western Europe, is also a prominent region, driven by stringent regulatory standards and increasing adoption of alternative treatments in livestock management. In Asia-Pacific, countries like China and India are emerging as key markets due to their large agricultural sectors and growing emphasis on enhancing animal health. Recent reports indicate that China's investment in peptide-based veterinary products has surged by approximately 25% over the past year, while India's expanding livestock sector is rapidly adopting these new technologies to address rising disease outbreaks.

Animal Antibacterial Peptide Market- Competitive Landscape:

The Animal Antibacterial Peptide Market's competitive landscape is defined by a vibrant blend of major pharmaceutical companies and forward-thinking biotech firms. In North America, prominent players such as Zoetis, Elanco, and Merck are at the forefront, leveraging their extensive R&D capabilities and established market presence to drive advancements in peptide-based therapies. These companies are complemented by emerging biotech firms that bring cutting-edge technologies and novel peptide solutions to the table. A notable instance of strategic collaboration in this market is the recent partnership between Elanco and PeptiSystems, aimed at co-developing targeted antimicrobial peptides for livestock. This alliance highlights the industry's trend towards combining expertise to tackle the growing challenge of antibiotic-resistant infections.

Recent Developments:

In February 2020, CARB-X funds Lytica Therapeutics up to $16.9 million to develop antibacterial peptides against multidrug-resistant Gram-negative bacteria, targeting infections in the lungs and other parts of the body. The project aims to overcome the current limitations of antimicrobial peptides.

In July 2023, BioCote Limited and Eco Finish established a strategic partnership to integrate BioCote technology into antimicrobial surfaces for residential and commercial pools. This collaboration introduces additives designed to inhibit bacteria, algae, viruses, and other microbes, thereby improving safety and protection for swimmers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alltech

Animal Health International, Inc.

Bayer AG

Boehringer Ingelheim International GmbH

Ceva Sante Animale

Dechra Pharmaceuticals PLC

Elanco Animal Health Incorporated

Hill's Pet Nutrition, Inc.

Jurox Pty Ltd

Kemin Industries, Inc.

Merck Animal Health

Novartis Animal Health

Phibro Animal Health Corporation

Vetoquinol S.A.

Virbac

Zoetis Inc.

Others

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Animal Antibacterial Peptide Market Overview

2. Executive Summary

3. Animal Antibacterial Peptide Key Market Trends

4. Animal Antibacterial Peptide Industry Study

5. Animal Antibacterial Peptide Market: COVID-19 Impact Analysis

6. Animal Antibacterial Peptide Market Landscape

7. Animal Antibacterial Peptide Market - By Type

8. Animal Antibacterial Peptide Market - By Source

9. Animal Antibacterial Peptide Market - By Application

10. Animal Antibacterial Peptide Market - By End-User

11. Animal Antibacterial Peptide Market- By Geography

12. Key Vendor Analysis- Animal Antibacterial Peptide Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â